|
|
前列腺素类滴眼液副作用的研究进展
|
Abstract:
前列腺素类滴眼液由于其降眼压效果显著、副作用少、一天一次的使用频率成为治疗青光眼的一线药物。但随着人们对前列腺素类药物运用和研究的进一步深入，其在眼部及眼外的副作用及其机制被逐步报道。与此同时，一些副作用更少、降眼压效果良好的新型前列腺素类药物的出现，为饱受传统前列腺素类药物副作用折磨的青光眼患者带来了福音。本文将对目前主要的前列腺素类药物的副作用及其机制作一综述，旨在为眼科医生合理选择前列腺素类药物，防治其副作用提供参考。
Prostaglandin eye drops have become first-line drugs for the treatment of glaucoma due to their significant efficacy of lowering intraocular pressure, few side effects, and the frequency of once a day. However, as the application and the study of it develops in depth, the intraocular and extraocular side effects of prostaglandin eye drops have gradually been reported. Simultaneously, the emergence of some new prostaglandin drugs with fewer side effects and comparable effects of lowering intraocular pressure has also brought the gospel to glaucoma patients who suffer from the side effects of traditional prostaglandin drugs. This article will review the side effects of the main prostaglandin drugs and the mechanisms of their side effects, aiming to provide a reference for ophthalmologists to rationally select prostaglandin drugs and prevent their side effects.
| [1] | Holló, G., Aung, T., Cantor, L.B. and Aihara, M. (2020) Cystoid Macular Edema Related to Cataract Surgery and Topical Prostaglandin Analogs: Mechanism, Diagnosis, and Management. Survey of Ophthalmology, 65, 496-512.
https://doi.org/10.1016/j.survophthal.2020.02.004 |
| [2] | Wu, G. and Morrell, A. (2000) Severe Hypotony Following Cataract Extraction in a Patient on Latanoprost. Eye, 14, 915-916. https://doi.org/10.1038/eye.2000.255 |
| [3] | Gupta, R. and Vernon, S.A. (2001) Choroidal Detachment Following Extracapsular Cataract Extraction in a Patient Treated with Latanoprost. British Journal of Ophthalmology, 85, 1268. https://doi.org/10.1136/bjo.85.10.1260i |
| [4] | Marques Pereira, M.L. and Katz, L.J. (2001) Choroidal Detachment after the Use of Topical Latanoprost. American Journal of Ophthalmology, 132, 928-929. https://doi.org/10.1016/S0002-9394(01)01143-6 |
| [5] | Sodhi, P.K., Sachdev, M.S., Gupta, A., Verma, L.K. and Ratan, S.K. (2004) Choroidal Detachment with Topical Latanoprost after Glaucoma Filtration Surgery. Annals of Pharmacotherapy, 38, 510-511.
https://doi.org/10.1345/aph.1D281 |
| [6] | Pathanapitoon, K. and Kunavisarut, P. (2005) Choroidal Detachment after Topical Prostaglandin Analogs: Case Report. Journal of the Medical Association of Thailand, 88, 1134-1136. |
| [7] | Cheggour, M. and Gambrelle, J. (2012) Massive Choroidal Detachment Secondary to Topical Use of Bimatoprost: Report of Two Cases. Journal Francais D’ophtalmologie, 35, 176-180. https://doi.org/10.1016/j.jfo.2011.09.009 |
| [8] | Sakai, H., Sakima, N., Nakamura, Y., Nakamura, Y., Hayakawa, K. and Sawaguchi, S. (2002) Ciliochoroidal Effusion Induced by Topical Latanoprost in a Patient with Sturge-Weber Syndrome. Japanese Journal of Ophthalmology, 46, 553-555. https://doi.org/10.1016/S0021-5155(02)00542-7 |
| [9] | Gambrelle, J., Denis, P., Kocaba, V. and Grange, J.D. (2008) Uveal Effusion Induced by Topical Travoprost in a Patient with Sturge-Weber-Krabbe Syndrome. Journal Francais D’ophtalmologie, 31, e19.
https://doi.org/10.1016/S0181-5512(08)74730-2 |
| [10] | Romano, M.R. and Lograno, M.D. (2007) Evidence for the Involvement of Cannabinoid CB1 Receptors in the Bimatoprost-Induced Contractions on the Human Isolated Ciliary Muscle. Investigative Ophthalmology & Visual Science, 48, 3677-3682. https://doi.org/10.1167/iovs.06-0896 |
| [11] | Ayaki, M., Tsuneyoshi, Y., Yuki, K., Tsubota, K. and Negishi, K. (2019) Latanoprost Could Exacerbate the Progression of Presbyopia. PLoS ONE, 14, e0211631. https://doi.org/10.1371/journal.pone.0211631 |
| [12] | Alphen, G.W., Wilhelm, P.B. and Elsenfeld, P.W. (1977) The Effect of Prostaglandins on the Isolated Internal Muscles of the Mammalian Eye, Including Man. Documenta Ophthalmologica, 42, 397-415.
https://doi.org/10.1007/BF02742255 |
| [13] | Crawford, K.S. and Kaufman, P.L. (1991) Dose-Related Effects of Prostaglandin F2 Alpha Isopropylester on Intraocular Pressure, Refraction, and Pupil Diameter in Monkeys. Investigative Ophthalmology & Visual Science, 32, 510-519. |
| [14] | Millar, J.C. and Kaufman, P.L. (1995) PGF2 Alpha/Pilocarpine Interactions on IOP and Accommodation in Monkeys. Experimental Eye Research, 61, 677-683. https://doi.org/10.1016/S0014-4835(05)80018-1 |
| [15] | Otsuka, N., Yoshitomi, T., Tsuchiya, K., Ukai, K., Ooki, C. and Ishikawa, S. (1996) Effects of Topical Application of Isopropyl Unoprostone on Refraction and Accommodation. Nippon Ganka Gakkai Zasshi, 100, 531-534. |
| [16] | Troiano, P., Oldani, A., Gozzini, C., Iraci, M., Dalpozzo, R., Baratta, M. and De Mattia, M. (2000) Latanoprost 0.005%: Evaluation of Its Effect on Accommodative Capacity. Acta ophthalmologica Scandinavica. Supplement, 232, 52-54. https://doi.org/10.1111/j.1600-0420.2000.tb01104.x |
| [17] | Kurtz, S., Leibovitch, I., Shemesh, G., Rothkoff, L. and Loewenstein, A. (2003) The Effect of Latanoprost on Accommodation in Young Patients with Ocular Hypertension. Journal of Glaucoma, 12, 54-56.
https://doi.org/10.1097/00061198-200302000-00011 |
| [18] | Bhat, S., Handa, S. and De, D. (2021) A Randomized Comparative Study of the Efficacy of Topical Latanoprost versus Topical Betamethasone Diproprionate Lotion in the Treatment of Localized Alopecia Areata. Indian Journal of Dermatology, Venereology and Leprology, 87, 42-48. https://doi.org/10.25259/IJDVL_787_19 |
| [19] | Johnstone, M.A. (1997) Hypertrichosis and Increased Pigmentation of Eyelashes and Adjacent Hair in the Region of the Ipsilateral Eyelids of Patients Treated with Unilateral Topical Latanoprost. American Journal of Ophthalmology, 124, 544-547. https://doi.org/10.1016/S0002-9394(14)70870-0 |
| [20] | Stein, J.D., Khawaja, A.P. and Weizer, J.S. (2021) Glaucoma in Adults—Screening, Diagnosis, and Management. JAMA, 325, 164-174. https://doi.org/10.1001/jama.2020.21899 |
| [21] | Steinsapir, K.D. and Steinsapir, S.M.G. (2021) Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery, 47, 658-665.
https://doi.org/10.1097/DSS.0000000000002928 |
| [22] | Esaki, Y., Katsuta, O., Kamio, H., Noto, T., Mano, H., Iwamura, R., Yoneda, K., Odani-Kawabata, N., Morishima, K. and Shams, N.K. (2020) The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice. Journal of Ocular Pharmacology and Therapeutics: The Official Journal of the Association for Ocular Pharmacology and Therapeutics, 36, 529-533. https://doi.org/10.1089/jop.2020.0003 |
| [23] | Peplinski, L.S. and Albiani Smith, K. (2004) Deepening of Lid Sulcus from Topical Bimatoprost Therapy. Optometry and Vision Science, 81, 574-577. https://doi.org/10.1097/01.opx.0000141791.16683.4a |
| [24] | Yang, H.K., Park, K.H., Kim, T.W. and Kim, D.M. (2009) Deepening of Eyelid Superior Sulcus during Topical Travoprost Treatment. Japanese Journal of Ophthalmology, 53, 176-179. https://doi.org/10.1007/s10384-008-0623-x |
| [25] | Jayaprakasam, A. and Ghazi-Nouri, S. (2010) Periorbital Fat Atrophy—An Unfamiliar Side Effect of Prostaglandin Analogues. Orbit, 29, 357-359. https://doi.org/10.3109/01676830.2010.527028 |
| [26] | Nakakura, S., Tabuchi, H. and Kiuchi, Y. (2011) Latanoprost Therapy after Sunken Eyes Caused by Travoprost or Bimatoprost. Optometry and Vision Science, 88, 1140-1144. https://doi.org/10.1097/OPX.0b013e3182231202 |
| [27] | Park, J., Cho, H.K. and Moon, J.I. (2011) Changes to Upper Eyelid Orbital Fat from Use of Topical Bimatoprost, Travoprost, and Latanoprost. Japanese Journal of Ophthalmology, 55, 22. https://doi.org/10.1007/s10384-010-0904-z |
| [28] | Inoue, K., Shiokawa, M., Wakakura, M. and Tomita, G. (2013) Deepening of the Upper Eyelid Sulcus Caused by 5 Types of Prostaglandin Analogs. Journal of Glaucoma, 22, 626-631. https://doi.org/10.1097/IJG.0b013e31824d8d7c |
| [29] | Kucukevcilioglu, M., Bayer, A. and Uysal, Y. (2014) Prostaglandin Associated Periorbitopathy in Patients Using Bimatoprost, Latanoprost and Travoprost. Clinical & Experimental Ophthalmology, 42, 126-131.
https://doi.org/10.1111/ceo.12163 |
| [30] | Sakata, R., Shirato, S. and Miyata, K. (2014) Incidence of Deepening of the Upper Eyelid Sulcus on Treatment with a Tafluprost Ophthalmic Solution. Japanese Journal of Ophthalmology, 58, 212-217.
https://doi.org/10.1007/s10384-013-0299-8 |
| [31] | Sarnoff, D.S. and Gotkin, R.H. (2015) Bimatoprost-Induced Chemical Blepharoplasty. Journal of Drugs in Dermatology, 14, 472-477. |
| [32] | Sakata, R., Fujishiro, T. and Saito, H. (2021) Recovery of Deepening of the Upper Eyelid Sulcus after Switching from Prostaglandin FP Receptor Agonists to EP2 Receptor Agonist: A 3-Month Prospective Analysis. Japanese Journal of Ophthalmology, 65, 591-597. https://doi.org/10.1007/s10384-021-00855-3 |
| [33] | Hikage, F., Ida, Y. and Ouchi, Y. (2021) Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts. Translational Vision Science & Technology, 10, 6.
https://doi.org/10.1167/tvst.10.4.6 |
| [34] | Bourne, R.R.A., Flaxman, S.R., Braithwaite, T., Cicinelli, M.V., Das, A., Jonas, J.B., Keeffe, J., Kempen, J.H., Leasher, J., Limburg, H., Naidoo, K., Pesudovs, K., Resnikoff, S., Silvester, A., Stevens, G.A., Tahhan, N., Wong, T.Y., Taylor, H.R. and Vision Loss Expert, G. (2017) Magnitude, Temporal Trends, and Projections of the Global Prevalence of Blindness and Distance and Near Vision Impairment: A Systematic Review and Meta-Analysis. The Lancet Global Health, 5, e888-e897. https://doi.org/10.1016/S2214-109X(17)30293-0 |
| [35] | Oogi, S., Nakakura, S. and Terao, E. (2020) One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome after Switch from Conventional Prostaglandin F2alfa to Omidenepag Isopropyl. Cureus, 12, e10064.
https://doi.org/10.7759/cureus.10064 |
| [36] | Wang, H., Masselos, K., Kalloniatis, M. and Phu, J. (2021) Headaches Related to Latanoprost in Open-Angle Glaucoma. Clinical and Experimental Optometry, 104, 625-633. https://doi.org/10.1080/08164622.2021.1878846 |
| [37] | Allison, K., Patel, D. and Alabi, O. (2020) Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus, 12, e11686. https://doi.org/10.7759/cureus.11686 |
| [38] | Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd Edition. Cephalalgia, 38, 1-211. https://doi.org/10.1177/0333102417738202 |
| [39] | Song, P., Wang, J., Bucan, K., Theodoratou, E., Rudan, I. and Chan, K.Y. (2017) National and Subnational Prevalence and Burden of Glaucoma in China: A Systematic Analysis. Journal of Global Health, 7, Article ID: 020705.
https://doi.org/10.7189/jogh.07.020705 |
| [40] | Weston, B.C. (2001) Migraine Headache Associated with Latanoprost. Archives of Ophthalmology, 119, 300-301. |
| [41] | Webb, T.E.R. (2021) A Review of Glaucoma Surgical Therapy. Veterinary Ophthalmology, 24, 34-38.
https://doi.org/10.1111/vop.12852 |
| [42] | Razeghinejad, M.R. and Lee, D. (2019) Managing Normal Tension Glaucoma by Lowering the Intraocular Pressure. Survey of Ophthalmology, 64, 111-116. https://doi.org/10.1016/j.survophthal.2018.07.003 |
| [43] | Guglielmi, P., Carradori, S., Campestre, C. and Poce, G. (2019) Novel Therapies for Glaucoma: A Patent Review (2013- 2019). Expert Opinion on Therapeutic Patents, 29, 769-780. https://doi.org/10.1080/13543776.2019.1653279 |
| [44] | Angeli, A. and Supuran, C.T. (2019) Prostaglandin Receptor Agonists as Antiglaucoma Agents (a Patent Review 2013- 2018). Expert Opinion on Therapeutic Patents, 29, 793-803. https://doi.org/10.1080/13543776.2019.1661992 |
| [45] | Aihara, M. (2021) Prostanoid Receptor Agonists for Glaucoma Treatment. Japanese Journal of Ophthalmology, 65, 581-590. https://doi.org/10.1007/s10384-021-00844-6 |
| [46] | Hellberg, M.R., McLaughlin, M.A., Sharif, N.A., DeSantis, L., Dean, T.R., Kyba, E.P., Bishop, J.E., Klimko, P.G., Zinke, P.W., Selliah, R.D., Barnes, G., DeFaller, J., Kothe, A., Landry, T., Sullivan, E.K., Andrew, R., Davis, A.A., Silver, L., Bergamini, M.V., Robertson, S., Weiner, A.L. and Sallee, V.L. (2002) Identification and Characterization of the Ocular Hypotensive Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist, and AL-6598, a DP Prostaglandin Receptor Agonist. Survey of Ophthalmology, 47, S13-S33.
https://doi.org/10.1016/S0039-6257(02)00293-X |
| [47] | Ota, T., Aihara, M., Narumiya, S. and Araie, M. (2005) The Effects of Prostaglandin Analogues on IOP in Prostanoid FP-Receptor-Deficient Mice. Investigative Ophthalmology & Visual Science, 46, 4159-4163.
https://doi.org/10.1167/iovs.05-0494 |
| [48] | Ota, T., Aihara, M., Saeki, T., Narumiya, S. and Araie, M. (2006) The Effects of Prostaglandin Analogues on Prostanoid EP1, EP2, and EP3 Receptor-Deficient Mice. Investigative Ophthalmology & Visual Science, 47, 3395-3399.
https://doi.org/10.1167/iovs.06-0100 |
| [49] | Saeki, T., Ota, T., Aihara, M. and Araie, M. (2009) Effects of Prostanoid EP Agonists on Mouse Intraocular Pressure. Investigative Ophthalmology & Visual Science, 50, 2201-2208. https://doi.org/10.1167/iovs.08-2800 |
| [50] | Winkler, N.S. and Fautsch, M.P. (2014) Effects of Prostaglandin Analogues on Aqueous Humor Outflow Pathways. Journal of Ocular Pharmacology and Therapeutics, 30, 102-109. https://doi.org/10.1089/jop.2013.0179 |
| [51] | Honrubia, F., García-Sánchez, J. and Polo, V. (2009) Conjunctival Hyperaemia with the Use of Latanoprost versus Other Prostaglandin Analogues in Patients with Ocular Hypertension or Glaucoma: A Meta-Analysis of Randomised Clinical Trials. British Journal of Ophthalmology, 93, 316. https://doi.org/10.1136/bjo.2007.135111 |
| [52] | Taketani, Y., Yamagishi, R., Fujishiro, T., Igarashi, M., Sakata, R. and Aihara, M. (2014) Activation of the Prostanoid FP Receptor Inhibits Adipogenesis Leading to Deepening of the Upper Eyelid Sulcus in Prostaglandin-Associated Periorbitopathy. Investigative Ophthalmology & Visual Science, 55, 1269-1276. https://doi.org/10.1167/iovs.13-12589 |
| [53] | Krishnamurthy, R., Senthil, S. and Garudadri, C.S. (2015) Late Postoperative Choroidal Detachment Following an Uneventful Cataract Surgery in a Patient on Topical Latanoprost. BMJ Case Reports, 2015, bcr2015211408.
https://doi.org/10.1136/bcr-2015-211408 |
| [54] | Bitton, E.O.D.M.F.F., Courey, C.O.D.F., Giancola, P.O.D., Diaconu, V.P., Wise, J.M.D. and Wittich, W.P.F.C. (2017) Effects of LATISSE (Bimatoprost 0.03 Percent Topical Solution) on the Ocular Surface. Clinical and Experimental Optometry, 100, 583-589. https://doi.org/10.1111/cxo.12507 |
| [55] | Jayanetti, V., Sandhu, S. and Lusthaus, J.A. (2020) The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma. Journal of Experimental Pharmacology, 12, 539-548.
https://doi.org/10.2147/JEP.S281187 |
| [56] | Duggan, S. (2018) Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval. Drugs, 78, 1925-1929.
https://doi.org/10.1007/s40265-018-1016-1 |
| [57] | Weinreb, R.N., Liebmann, J.M. and Martin, K.R. (2018) Latanoprostene Bunod 0.024% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings. Journal of Glaucoma, 27, 7-15.
https://doi.org/10.1097/IJG.0000000000000831 |
| [58] | Tong, L., Matsuura, E., Takahashi, M., Nagano, T. and Kawazu, K. (2019) Effects of Anti-Glaucoma Prostaglandin Ophthalmic Solutions on Cultured Human Corneal Epithelial Cells. Current Eye Research, 44, 856-862.
https://doi.org/10.1080/02713683.2019.1597127 |
| [59] | Lee, H.J., Jun, R.M., Cho, M.S. and Choi, K.-R. (2015) Comparison of the Ocular Surface Changes Following the Use of Two Different Prostaglandin F2α Analogues Containing Benzalkonium Chloride or Polyquad in Rabbit Eyes. Cutaneous and Ocular Toxicology, 34, 195-202. https://doi.org/10.3109/15569527.2014.944650 |
| [60] | Nam, M. and Kim, S.W. (2021) Changes in Corneal Epithelial Thickness Induced by Topical Antiglaucoma Medications. Journal of Clinical Medicine, 10, 3464. https://doi.org/10.3390/jcm10163464 |
| [61] | Takada, Y., Yamanaka, O., Okada, Y., Sumioka, T., Reinach, P.S. and Saika, S. (2020) Effects of a Prostaglandin F2alpha Derivative Glaucoma Drug on EGF Expression and E-cadherin Expression in a Corneal Epithelial Cell Line. Cutaneous and Ocular Toxicology, 39, 75-82. https://doi.org/10.1080/15569527.2020.1722152 |
| [62] | Bergonzi, C., Giani, A., Blini, M., Marchi, S., Luccarelli, S. and Staurenghi, G. (2010) Evaluation of Prostaglandin Analogue Effects on Corneal Keratocyte Density Using Scanning Laser Confocal Microscopy. Journal of Glaucoma, 19, 617-621. https://doi.org/10.1097/IJG.0b013e3181ca7c7a |
| [63] | Rossi, G.C., Blini, M., Scudeller, L., Ricciardelli, G., Depolo, L., Amisano, A., Bossolesi, L., Pasinetti, G.M. and Bianchi, P.E. (2013) Effect of Preservative-Free Tafluprost on Keratocytes, Sub-Basal Nerves, and Endothelium: A Single-Blind One-Year Confocal Study on Naive or Treated Glaucoma and Hypertensive Patients versus a Control Group. Journal of Ocular Pharmacology and Therapeutics, 29, 821-825. https://doi.org/10.1089/jop.2013.0069 |
| [64] | Ranno, S., Fogagnolo, P., Rossetti, L., Orzalesi, N. and Nucci, P. (2011) Changes in Corneal Parameters at Confocal Microscopy in Treated Glaucoma Patients. Clinical Ophthalmology (Auckland, NZ), 5, 1037-1042.
https://doi.org/10.2147/OPTH.S22874 |
| [65] | Baratz, K.H., Nau, C.B., Winter, E.J., McLaren, J.W., Hodge, D.O., Herman, D.C. and Bourne, W.M. (2006) Effects of Glaucoma Medications on Corneal Endothelium, Keratocytes, and Subbasal Nerves among Participants in the Ocular Hypertension Treatment Study. Cornea, 25, 1046-1052. https://doi.org/10.1097/01.ico.0000230499.07273.c5 |
| [66] | Martone, G., Frezzotti, P., Tosi, G.M., Traversi, C., Mittica, V., Malandrini, A., Pichierri, P., Balestrazzi, A., Motolese, P.A., Motolese, I. and Motolese, E. (2009) An in Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy with Preservative on Corneal Innervation and Morphology. American Journal of Ophthalmology, 147, 725-735.e721. https://doi.org/10.1016/j.ajo.2008.10.019 |
| [67] | Labbe, A., Alalwani, H., Van Went, C., Brasnu, E., Georgescu, D. and Baudouin, C. (2012) The Relationship between Subbasal Nerve Morphology and Corneal Sensation in Ocular Surface Disease. Investigative Ophthalmology & Visual Science, 53, 4926-4931. https://doi.org/10.1167/iovs.11-8708 |
| [68] | Villani, E., Sacchi, M., Magnani, F., Nicodemo, A., Williams, S.E., Rossi, A., Ratiglia, R., De Cilla, S. and Nucci, P. (2016) The Ocular Surface in Medically Controlled Glaucoma: An in Vivo Confocal Study. Investigative Ophthalmology & Visual Science, 57, 1003-1010. https://doi.org/10.1167/iovs.15-17455 |
| [69] | Agnifili, L., Brescia, L., Oddone, F., Sacchi, M., D’Ugo, E., Di Marzio, G., Perna, F., Costagliola, C. and Mastropasqua, R. (2019) The Ocular Surface after Successful Glaucoma Filtration Surgery: A Clinical, in Vivo Confocal Microscopy, and Immune-Cytology Study. Scientific Reports, 9, Article No. 11299.
https://doi.org/10.1038/s41598-019-47823-z |
| [70] | Agnifili, L., Brescia, L., Villani, E., D’Onofrio, G., Figus, M., Oddone, F., Nucci, P. and Mastropasqua, R. (2022) In Vivo Confocal Microscopy of the Corneal Sub-Basal Nerve Plexus in Medically Controlled Glaucoma. Microscopy and Microanalysis, 1-8. https://doi.org/10.1017/S1431927621013969 |
| [71] | Society, E.G. (2020) Terminology and Guidelines for Glaucoma. 5th Edition. |
| [72] | Bafa, M., Georgopoulos, G., Mihas, C., Stavrakas, P., Papaconstantinou, D. and Vergados, I. (2011) The Effect of Prostaglandin Analogues on Central Corneal Thickness of Patients with Chronic Open-Angle Glaucoma: A 2-Year Study on 129 Eyes. Acta Ophthalmologica, 89, 448-451. https://doi.org/10.1111/j.1755-3768.2009.01731.x |
| [73] | Duygu, U.U. (2018) The Effect of Prostaglandin Analogues on Central Corneal Thickness. International Journal of Ophthalmology and Clinical Research, 5, 84. https://doi.org/10.23937/2378-346X/1410084 |
| [74] | Jang, M., Kang, K.E. and Cho, B.J. (2020) Effect of Prostaglandin Analogues on Central Corneal Thickness: 3-Year Follow-Up Results. Korean Journal of Ophthalmology: KJO, 34, 347-352. https://doi.org/10.3341/kjo.2019.0129 |
| [75] | Lass, J., Eriksson, G., Osterling, L. and Simpson, C. (2001) Comparison of the Corneal Effects of Latanoprost, Fixed Combination Latanoprost-Timolol, and Timolol: A Double-Masked, Randomized, One-Year Study. Ophthalmology, 108, 264-271. https://doi.org/10.1016/S0161-6420(00)00531-5 |
| [76] | Wierzbowska, J., ？agocka, A., Siemiatkowska, A., Robaszkiewicz, J., Stankiewicz, A. and Sierdziński, J. (2009) The Impact of Common Classes of Topical Antiglaucoma Medications on Central Corneal Thickness—Own Observations. Klinika Oczna, 111, 323-326. |
| [77] | Schwartz, G.S. and Holland, E.J. (1998) Iatrogenic Limbal Stem Cell Deficiency. Cornea, 17, 31-37.
https://doi.org/10.1097/00003226-199801000-00006 |
| [78] | Liang, H., Baudouin, C., Pauly, A. and Brignole-Baudouin, F. (2008) Conjunctival and Corneal Reactions in Rabbits Following Short- and Repeated Exposure to Preservative-Free Tafluprost, Commercially Available Latanoprost and 0.02% Benzalkonium Chloride. British Journal of Ophthalmology, 92, 1275-1282.
https://doi.org/10.1136/bjo.2008.138768 |
| [79] | Pauly, A., Roubeix, C., Liang, H., Brignole-Baudouin, F. and Baudouin, C. (2012) In Vitro and in Vivo Comparative Toxicological Study of a New Preservative-Free Latanoprost Formulation. Investigative Ophthalmology & Visual Science, 53, 8172-8180. https://doi.org/10.1167/iovs.12-10766 |
| [80] | Mastropasqua, R., Agnifili, L., Fasanella, V., Curcio, C., Brescia, L., Lanzini, M., Fresina, M., Mastropasqua, L. and Marchini, G. (2015) Corneoscleral Limbus in Glaucoma Patients: In Vivo Confocal Microscopy and Immunocytological Study. Investigative Ophthalmology & Visual Science, 56, 2050-2058. https://doi.org/10.1167/iovs.14-15890 |
| [81] | Mastropasqua, R., Agnifili, L., Fasanella, V., Lappa, A., Brescia, L., Lanzini, M., Oddone, F., Perri, P. and Mastropasqua, L. (2016) In Vivo Distribution of Corneal Epithelial Dendritic Cells in Patients with Glaucoma. Investigative Ophthalmology & Visual Science, 57, 5996-6002. https://doi.org/10.1167/iovs.16-20333 |
| [82] | El Ameen, A., Vandermeer, G., Khanna, R.K. and Pisella, P.J. (2019) Objective Ocular Surface Tolerance in Patients with Glaucoma Treated with Topical Preserved or Unpreserved Prostaglandin Analogues. European Journal of Ophthalmology, 29, 645-653. https://doi.org/10.1177/1120672118805877 |
| [83] | Hedengran, A., Steensberg, A.T., Virgili, G., Azuara-Blanco, A. and Kolko, M. (2020) Efficacy and Safety Evaluation of Benzalkonium Chloride Preserved Eye-Drops Compared with Alternatively Preserved and Preservative-Free Eye- Drops in the Treatment of Glaucoma: A Systematic Review and Meta-Analysis. British Journal of Ophthalmology, 104, 1512-1518. https://doi.org/10.1136/bjophthalmol-2019-315623 |
| [84] | Moreno, M., Villena, A., Cabarga, C., Sanchez-Font, E. and Garcia-Campos, J. (2003) Impression Cytology of the Conjunctival Epithelium after Antiglaucomatous Treatment with Latanoprost. European Journal of Ophthalmology, 13, 553-559. https://doi.org/10.1177/112067210301300608 |
| [85] | Ammar, D.A., Noecker, R.J. and Kahook, M.Y. (2010) Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells. Advances in Therapy, 27, 837-845. https://doi.org/10.1007/s12325-010-0070-1 |
| [86] | Yang, Y., Huang, C., Lin, X., Wu, Y., Ouyang, W., Tang, L., Ye, S., Wang, Y., Li, W., Zhang, X. and Liu, Z. (2018) 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice. Investigative Ophthalmology & Visual Science, 59, 3375-3384. https://doi.org/10.1167/iovs.18-24013 |
| [87] | Hedengran, A., Begun, X., Mullertz, O., Mouhammad, Z., Vohra, R., Bair, J., Dartt, D.A., Cvenkel, B., Heegaard, S., Petrovski, G. and Kolko, M. (2021) Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in Vitro. Biomed Hub, 6, 69-75. https://doi.org/10.1159/000517845 |
| [88] | Gipson, I.K. (2016) Goblet Cells of the Conjunctiva: A Review of Recent Findings. Progress in Retinal and Eye Research, 54, 49-63. https://doi.org/10.1016/j.preteyeres.2016.04.005 |
| [89] | Mullertz, O., Hedengran, A., Mouhammad, Z.A., Freiberg, J., Nagymihaly, R., Jacobsen, J., Larsen, S.W., Bair, J., Utheim, T., Dartt, D.A., Heegaard, S., Petrovski, G. and Kolko, M. (2021) Impact of Benzalkonium Chloride-Pre- served and Preservative-Free Latanoprost Eye Drops on Cultured Human Conjunctival Goblet Cells upon Acute Exposure and Differences in Physicochemical Properties of the Eye Drops. BMJ Open Ophthalmology, 6, e000892.
https://doi.org/10.1136/bmjophth-2021-000892 |
| [90] | Addicks, E.M., Quigley, H.A., Green, W.R. and Robin, A.L. (1983) Histologic Characteristics of Filtering Blebs in Glaucomatous Eyes. Archives of Ophthalmology, 101, 795-798.
https://doi.org/10.1001/archopht.1983.01040010795021 |
| [91] | Amar, N., Labbe, A., Hamard, P., Dupas, B. and Baudouin, C. (2008) Filtering Blebs and Aqueous Pathway an Immunocytological and In Vivo Confocal Microscopy Study. Ophthalmology, 115, 1154-1161.e1154.
https://doi.org/10.1016/j.ophtha.2007.10.024 |
| [92] | Ciancaglini, M., Carpineto, P., Agnifili, L., Nubile, M., Fasanella, V., Mattei, P.A. and Mastropasqua, L. (2009) Conjunctival Characteristics in Primary Open-Angle Glaucoma and Modifications Induced by Trabeculectomy with Mitomycin C: an In Vivo Confocal Microscopy Study. British Journal of Ophthalmology, 93, 1204-1209.
https://doi.org/10.1136/bjo.2008.152496 |
| [93] | Staso, S.D., Agnifili, L., Gregorio, A.D. Climastone, H., Galassi, E., Fasanella, V. and Ciancaglini, M. (2017) Three- Dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients before and after Trabeculectomy. In Vivo, 31, 1081-1088. https://doi.org/10.21873/invivo.11173 |
| [94] | Ciancaglini, M., Carpineto, P., Agnifili, L., Nubile, M., Lanzini, M., Fasanella, V. and Mastropasqua, L. (2008) Filtering Bleb Functionality: A Clinical, Anterior Segment Optical Coherence Tomography and in Vivo Confocal Microscopy Study. Journal of Glaucoma, 17, 308-317. https://doi.org/10.1097/IJG.0b013e31815c3a19 |
| [95] | Mastropasqua, L., Agnifili, L., Ciancaglini, M., Nubile, M., Carpineto, P., Fasanella, V., Figus, M., Lazzeri, S. and Nardi, M. (2010) In Vivo Analysis of Conjunctiva in Gold Micro Shunt Implantation for Glaucoma. British Journal of Ophthalmology, 94, 1592-1596. https://doi.org/10.1136/bjo.2010.179994 |
| [96] | Agnifili, L., Carpineto, P., Fasanella, V., Mastropasqua, R., Zappacosta, A., Di Staso, S., Costagliola, C. and Mastropasqua, L. (2012) Conjunctival Findings in Hyperbaric and Low-Tension Glaucoma: An In Vivo Confocal Microscopy Study. Acta Ophthalmologica, 90, e132-e137. https://doi.org/10.1111/j.1755-3768.2011.02255.x |
| [97] | Mastropasqua, L., Agnifili, L., Salvetat, M.L., Ciancaglini, M., Fasanella, V., Nubile, M., Mastropasqua, R., Zeppieri, M. and Brusini, P. (2012) In Vivo Analysis of Conjunctiva in Canaloplasty for Glaucoma. British Journal of Ophthalmology, 96, 634-639. https://doi.org/10.1136/bjophthalmol-2011-301058 |
| [98] | Mastropasqua, L., Agnifili, L., Mastropasqua, R., Fasanella, V., Nubile, M., Toto, L., Carpineto, P. and Ciancaglini, M. (2014) In Vivo Laser Scanning Confocal Microscopy of the Ocular Surface in Glaucoma. Microscopy and Microanalysis, 20, 879-894. https://doi.org/10.1017/S1431927614000324 |
| [99] | Mastropasqua, R., Fasanella, V., Pedrotti, E., Lanzini, M., Di Staso, S., Mastropasqua, L. and Agnifili, L. (2014) Trans-Conjunctival Aqueous Humor Outflow in Glaucomatous Patients Treated with Prostaglandin Analogues: An In Vivo Confocal Microscopy Study. Graefe’s Archive for Clinical and Experimental Ophthalmology, 252, 1469-1476.
https://doi.org/10.1007/s00417-014-2664-9 |
| [100] | Mastropasqua, R., Agnifili, L., Fasanella, V., Toto, L., Brescia, L., Di Staso, S., Doronzo, E. and Marchini, G. (2016) Uveo-Scleral Outflow Pathways after Ultrasonic Cyclocoagulation in Refractory Glaucoma: An Anterior Segment Optical Coherence Tomography and in Vivo Confocal Study. British Journal of Ophthalmology, 100, 1668-1675.
https://doi.org/10.1136/bjophthalmol-2015-308069 |
| [101] | Ciancaglini, M., Carpineto, P., Agnifili, L., Nubile, M., Fasanella, V. and Mastropasqua, L. (2008) Conjunctival Modifications in Ocular Hypertension and Primary Open Angle Glaucoma: An In Vivo Confocal Microscopy Study. Investigative Ophthalmology & Visual Science, 49, 3042-3048. https://doi.org/10.1167/iovs.07-1201 |
| [102] | Siebelmann, S., Gehlsen, U., Huttmann, G., Koop, N., Bolke, T., Gebert, A., Stern, M.E., Niederkorn, J.Y. and Steven, P. (2013) Development, Alteration and Real Time Dynamics of Conjunctiva-Associated Lymphoid Tissue. PLoS ONE, 8, e82355. https://doi.org/10.1371/journal.pone.0082355 |
| [103] | Agnifili, L., Mastropasqua, R., Fasanella, V., Di Staso, S., Mastropasqua, A., Brescia, L. and Mastropasqua, L. (2014) In Vivo Confocal Microscopy of Conjunctiva-Associated Lymphoid Tissue in Healthy Humans. Investigative Ophthalmology & Visual Science, 55, 5254-5262. https://doi.org/10.1167/iovs.14-14365 |
| [104] | Mastropasqua, R., Agnifili, L., Fasanella, V., Nubile, M., Gnama, A.A., Falconio, G., Perri, P., Di Staso, S. and Mariotti, C. (2017) The Conjunctiva-Associated Lymphoid Tissue in Chronic Ocular Surface Diseases. Microscopy and Microanalysis, 23, 697-707. https://doi.org/10.1017/S1431927617000538 |
| [105] | Aydin Kurna, S., Acikgoz, S., Altun, A., Ozbay, N., Sengor, T. and Olcaysu, O.O. (2014) The Effects of Topical Antiglaucoma Drugs as Monotherapy on the Ocular Surface: A Prospective Study. Journal of Ophthalmology, 2014, Article ID: 460483. https://doi.org/10.1155/2014/460483 |
| [106] | Cunniffe, M.G., Medel-Jimenez, R. and Gonzalez-Candial, M. (2011) Topical Antiglaucoma Treatment with Prostaglandin Analogues May Precipitate Meibomian Gland Disease. Ophthalmic Plastic & Reconstructive Surgery, 27, e128- e129. https://doi.org/10.1097/IOP.0b013e318201d32f |
| [107] | Mocan, M.C., Uzunosmanoglu, E., Kocabeyoglu, S., Karakaya, J. and Irkec, M. (2016) The Association of Chronic Topical Prostaglandin Analog Use with Meibomian Gland Dysfunction. Journal of Glaucoma, 25, 770-774.
https://doi.org/10.1097/IJG.0000000000000495 |
| [108] | Cho, W.H., Lai, I.C., Fang, P.C., Chien, C.C., Tseng, S.L., Lai, Y.H., Huang, Y.T. and Kuo, M.T. (2018) Meibomian Gland Performance in Glaucomatous Patients with Long-Term Instillation of IOP-Lowering Medications. Journal of Glaucoma, 27, 176-183. https://doi.org/10.1097/IJG.0000000000000841 |
| [109] | Arita, R., Itoh, K., Maeda, S., Maeda, K., Furuta, A., Tomidokoro, A., Aihara, M. and Amano, S. (2012) Effects of Long-Term Topical Anti-Glaucoma Medications on Meibomian Glands. Graefe’s Archive for Clinical and Experimental Ophthalmology, 250, 1181-1185. https://doi.org/10.1007/s00417-012-1943-6 |
| [110] | Ha, J.Y., Sung, M.S. and Park, S.W. (2019) Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues. Chonnam Medical Journal, 55, 156-162.
https://doi.org/10.4068/cmj.2019.55.3.156 |
| [111] | Wong, A.B.C., Wang, M.T.M., Liu, K., Prime, Z.J., Danesh-Meyer, H.V. and Craig, J.P. (2018) Exploring Topical Anti-Glaucoma Medication Effects on the Ocular Surface in the Context of the Current Understanding of Dry Eye. The Ocular Surface, 16, 289-293. https://doi.org/10.1016/j.jtos.2018.03.002 |
| [112] | Su, C.C., Lee, Y.C. and Lee, P.R.C. (2021) Assessment of Ocular Surface Disease in Glaucoma Patients with Benzalkonium Chloride-Preserved Latanoprost Eye Drops: A Short-Term Longitudinal Study. Graefe’s Archive for Clinical and Experimental Ophthalmology, 259, 1243-1251. https://doi.org/10.1007/s00417-020-05067-y |
| [113] | Sedlak, L., Zych, M., Wojnar, W. and Wygledowska-Promienska, D. (2019) Effect of Topical Prostaglandin F2alpha Analogs on Selected Oxidative Stress Parameters in the Tear Film. Medicina (Kaunas), 55, 366.
https://doi.org/10.3390/medicina55070366 |
| [114] | Hu, J., Vu, J.T., Hong, B. and Gottlieb, C. (2020) Uveitis and Cystoid Macular Oedema Secondary to Topical Prostaglandin Analogue Use in Ocular Hypertension and Open Angle Glaucoma. The British Journal of Ophthalmology, 104, 1040-1044. https://doi.org/10.1136/bjophthalmol-2019-315280 |
| [115] | Olesen, J., Burstein, R., Ashina, M. and Tfelt-Hansen, P. (2009) Origin of Pain in Migraine: Evidence for Peripheral Sensitisation. The Lancet Neurology, 8, 679-690. https://doi.org/10.1016/S1474-4422(09)70090-0 |
| [116] | (MHRA) M.a.H.p.R.A. (2011) Latanoprost Drug Analysis Print, 7 May 2011.
http://www.mhra.gov.uk/home/groups/public/documents
/sentineldocuments/dap_1306406731772.pdf |
| [117] | Massimo, L., Micelli Ferrari, L., Nikolopoulou Gisotti, E., Zito, R., MicelliFerrari, T., Anna, F. and Bordinone, M.A. (2021) Granulomatous Uveitis and Choroidal Detachment in a Patient after Topical Treatment with Bimatoprost: A Case Report. European Journal of Ophthalmology. https://doi.org/10.1177/1120672121990573 |
| [118] | De Smit, E., Theodorou, M., Hildebrand, G.D. and Bloom, P. (2011) Heart Block Following Topical Latanoprost Treatment. BMJ Case Reports, 2011, bcr0820114607. https://doi.org/10.1136/bcr.08.2011.4607 |
